Facebook tracking pixel

Coming Soon

S10.AI's Next-Generation Telehealth Platform

R31.9
ICD-10-CM
Blood in Urine

Understanding blood in urine (hematuria) is crucial for accurate clinical documentation and medical coding. This resource provides information on diagnosing and documenting hematuria, including relevant ICD-10 codes, SNOMED CT concepts, and differential diagnoses for both gross hematuria and microscopic hematuria. Learn about common causes, symptoms, and diagnostic tests associated with blood in the urine to ensure proper patient care and accurate healthcare records.

Also known as

Hematuria
Blood in Urine

Diagnosis Snapshot

Key Facts
  • Definition : Presence of red blood cells in the urine, visible or microscopic.
  • Clinical Signs : Pink, red, or brown urine; flank pain; painful urination; frequent urination.
  • Common Settings : Primary care, urgent care, nephrology, urology.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC R31.9 Coding
R31

Hematuria

Blood in urine, unspecified cause.

N00-N99

Diseases of the genitourinary system

Covers various urinary tract conditions that can cause hematuria.

I60-I69

Intracranial hemorrhage

Bleeding within the skull can sometimes present with hematuria.

D59

Other nutritional anemias

Certain anemias can cause or be associated with hematuria.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the hematuria traumatic?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Blood in urine, visible or microscopic.
Kidney stones obstructing urinary tract.
Bladder infection causing bloody urine.

Documentation Best Practices

Documentation Checklist
  • Document macroscopic vs microscopic hematuria.
  • Specify if blood is visible or only detected via testing.
  • Note onset, duration, and frequency of hematuria.
  • Document associated symptoms like pain, dysuria, or fever.
  • Record relevant medical history, medications, and family history.

Coding and Audit Risks

Common Risks
  • Unspecified Hematuria

    Coding hematuria without specifying type (gross vs microscopic) or cause can lead to claim denials and inaccurate quality reporting. ICD-10 requires greater specificity.

  • Missed Underlying Cause

    Focusing solely on hematuria without coding the underlying condition (e.g., UTI, kidney stones) impacts reimbursement and clinical documentation integrity.

  • Trauma vs. Medical Hematuria

    Incorrectly coding traumatic hematuria as a medical condition or vice-versa leads to inaccurate data reporting and potential compliance issues.

Mitigation Tips

Best Practices
  • Document hematuria etiology: ICD-10 R31.x, N02.x, CDI query
  • Microscopic vs. gross hematuria: coding, clinical significance
  • Rule out malignancy, infection: proper ICD-10, CDI, compliance
  • Medication review: anticoagulants, nephrotoxic drugs
  • Repeat urinalysis for accurate diagnosis, coding, billing

Clinical Decision Support

Checklist
  • Confirm visible or microscopic hematuria (ICD-10 R31.x)
  • Review medication list for nephrotoxic drugs
  • Assess for urinary tract infection (UTI) symptoms
  • Consider recent trauma, exercise, or menstruation
  • Order urinalysis, urine culture, and imaging if indicated

Reimbursement and Quality Metrics

Impact Summary
  • Impact: Accurate coding (N39.0, R31) maximizes reimbursement for hematuria evaluation and management.
  • Impact: Proper documentation of blood in urine supports medical necessity for urinalysis, microscopy, and imaging.
  • Impact: Coding blood in urine impacts quality metrics related to early diagnosis of urinary tract infections, kidney stones, and bladder cancer.
  • Impact: Correct hematuria reporting improves hospital data accuracy for population health management and resource allocation.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: What is the initial diagnostic workup for asymptomatic microscopic hematuria in adults, considering current guidelines and best practices?

A: Asymptomatic microscopic hematuria (AMH) in adults necessitates a thorough evaluation to rule out significant underlying pathology. Current guidelines, including those from the American Urological Association (AUA), recommend a staged approach. The initial workup typically involves a detailed history, physical examination, urinalysis with microscopy to confirm hematuria, and urine culture to exclude infection. Further investigation with renal function tests (serum creatinine, eGFR) is crucial. Depending on patient risk factors (age, smoking history, family history of urologic malignancy), imaging studies such as renal and bladder ultrasound, or CT urography may be warranted. Consider implementing a risk-stratified approach for AMH to optimize resource utilization and minimize unnecessary testing while ensuring timely detection of serious conditions. Explore how S10.AI can assist in streamlining this process by automating guideline adherence checks and generating personalized diagnostic pathways.

Q: How do I differentiate between glomerular and non-glomerular causes of hematuria in a patient presenting with blood in their urine, utilizing laboratory and imaging findings?

A: Differentiating between glomerular and non-glomerular hematuria requires integrating clinical, laboratory, and imaging findings. Glomerular hematuria typically presents with red blood cell casts and dysmorphic red blood cells on urine microscopy, often accompanied by proteinuria. Non-glomerular hematuria usually features isomorphic red blood cells without casts or significant proteinuria. Laboratory tests such as urine sediment analysis and assessment of renal function are essential. Imaging modalities like renal ultrasound can help identify structural abnormalities suggesting non-glomerular etiologies like kidney stones, tumors, or cysts. In cases where the distinction remains challenging, consider a nephrology consult for further evaluation, including a renal biopsy if indicated. Learn more about how S10.AI can facilitate differential diagnosis by correlating laboratory and imaging results with established diagnostic criteria for hematuria.

Quick Tips

Practical Coding Tips
  • Code hematuria, not 'blood in urine'
  • Check for documentation of cause
  • Consider laterality: R, L, bilateral
  • NCI Thesaurus: C15186 for mapping
  • ICD-10 R31.x, N02.x, or other

Documentation Templates

Patient presents with hematuria, also documented as blood in urine.  The onset, duration, and frequency of the hematuria were documented.  Associated symptoms such as dysuria, urinary urgency, frequency, flank pain, abdominal pain, or fever were explored and documented.  The patient's medical history, including prior episodes of hematuria, urinary tract infections, kidney stones, bladder cancer, prostate problems (in males), family history of kidney disease, recent trauma, use of anticoagulants, NSAIDs, or other medications known to cause hematuria, and relevant surgical history were reviewed. Physical examination findings, including vital signs, abdominal examination, costovertebral angle tenderness, and presence of edema, were noted.  Differential diagnoses considered include urinary tract infection, nephrolithiasis, bladder cancer, kidney disease, trauma, medication-induced hematuria, and benign prostatic hyperplasia (in males).  Preliminary diagnostic testing may include urinalysis with microscopic examination, urine culture, and potentially blood tests such as a complete blood count (CBC), basic metabolic panel (BMP), and coagulation studies.  Further evaluation with imaging studies such as ultrasound, CT scan, or cystoscopy may be warranted depending on the initial findings and clinical suspicion.  Treatment plan will be determined based on the underlying cause of the hematuria and may include antibiotics for infection, pain management, referral to urology for further evaluation and management of suspected urological conditions, or other interventions as clinically indicated.  Patient education regarding potential causes, diagnostic workup, and treatment options for hematuria was provided.  Follow-up care and monitoring were discussed and scheduled as appropriate.